What should I Know Regarding Pregnancy, Nursing and Administering Fenofibrate to Children or the Elderly?
If you are PREGNANT
- Requires a Risk/Benefit Assessment:
If you are NURSING
- Absolute Contraindication: AVOID BREASTFEEDING DURING TREATMENT AND FOR 5 DAYS AFTER LAST DOSE PER MANUF
If you are an adult over 60
- Management or Monitoring Precaution: General-Elderly patients and patients with diabetes, hypothyroidism, or renal insufficiency are at increased risk for serious muscle toxicity. Renal-Avoid use in patients with mild to moderate renal impairment. Contraindicated in those with severe renal impairment. Consider monitoring renal function.
Giving Fenofibrate to a child under 12
- Management or Monitoring Precaution: Safety and efficacy not established in pediatrics.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.